openPR Logo
Press release

HIV Diagnostics Market forecast to grow at 9.5% CAGR up to 2023

07-03-2017 07:02 AM CET | Health & Medicine

Press release from: Global Market Insights, Inc.

Global Market Insights, Inc.

Global Market Insights, Inc.

According to research report “HIV Diagnostics Market Size By Product [Antibody Tests (HIV-1 Screening, ELISA/EIA, Home Access Dried Blood Spot, Rapid Test, HIV-1 Confirmatory Steps, Western Blot, Indirect Immunoflorescent Antibody Assay (IIFA), Line Immunoassay , RadioImmuno Precipitation Assay (RIPA), HIV-2 & Group O Test, Blood Antibody, Dried Blood Spot), Viral Identification Assay (p24 Antigen, Qualitative PCR, Viral Culture), CD4, Viral Load, Early Infant Diagnosis], Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, South Africa, Brazil), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023” by Global Market Insights, Inc. says Global HIV Diagnostics Market size contributed about $2.41 billion for 2015 and is expected to register CAGR of about 9.6% by end of forecast period.

Overview:

Rising cases of HIV (human immunodeficiency virus) and fast medical breakthroughs in terms of point of care diagnostics is predicted to drive HIV diagnostics market trends during forecast timeline.
HIV is found to be most common ailment, particularly in resource limited areas due to low health consciousness among the people and successful execution of antiretroviral treatment program. Rising occurrence of HIV has resulted in growing concerns among government to promote investments in events aimed at eradicating burden prices of HIV. Many such events include encouraging people to go for regular checkups. Multinational healthcare units like UNITAID spread HIV awareness and fund new technologies for treating and annihilating HIV.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/491

Increasing point of care diagnostics sector is projected to favorably affect global HIV diagnostics industry. Different aspects like cost efficacy, toughness, minimal device requirement and quick diagnosis are anticipated to promote HIV point of care diagnostics sector. Technological breakthroughs in biochemical engineering for designing these tests in order to permit consecutive identification and quantification of many targets with use of limited resource settings are projected to propel industry expansion.

Product Trends:

Global HIV diagnostics industry is segmented into various products like viral load, early infant diagnosis, antibody tests, viral identification assay and CD4.

Antibody tests segment is sub-segmented into western blot tests, HIV-1 screening tests, dried blood spot tests, ELISA (enzyme linked immunosorbent assay) tests, HIV- confirmatory tests, rapid test, western blot tests, line immunoassay, blood anti body tests, RIPA (radio immuno precipitation assay) tests, HIV-2 & group O tests and indirect immunofluorescent antibody assay (IIFA) tests.

This segment is predicted to contribute largely to HIV diagnostics market share during forecast timeline and is projected to surpass $1.6 billion by end of 2023. Extensive use and launching of modern point of care methods intended to surpass the cell distinguishing limitations and offer accurate outcomes will promote the segment expansion.

Browse key industry insights spread across 126 pages with 84 market data tables & 42 figures & charts from this 2017 report HIV Diagnostics Market in detail along with the table of contents at:

https://www.gminsights.com/industry-analysis/hiv-diagnostics-market

Viral identification assay segment is sub-segmented into viral culture, p24 antigen and qualitative PCR (polymerase chain reaction). Viral culture assay sub segment projected to touch $530 million by end of 2023 led the segment.

Viral load and CD4 segments are projected to register comparatively high CAGR of 9.91% and 10.2% during forecast timeline owing to increasing industry penetration as well as expansion of point of care diagnostics methods for such tests that would improve marketability in limited resource settings.

Regional Trends:

Global HIV diagnostics market is segmented into North America, Asia Pacific, Middle East & Africa, Europe and Latin America.

North America HIV diagnostics market price was evaluated at $947 million for 2015 and it dominated the global industry during the year. Factors like rapid acceptance of technologically modernized diagnostic solutions service providers and growing demand for point of care tests in the region has promoted regional industry expansion.

Asia Pacific HIV diagnostics industry is projected to register CAGR of 10.8% during forecast timeline due to enhancement in healthcare services coupled with rise in levels of HIV consciousness amongst the population of the region. Further, the region possesses large pool of patients suffering from HIV ailment and this is projected to stimulate regional industry growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/491

Competitive Trends:

Key industry participants profiled in the report include Apogee Flow Systems Limited, Abbott Healthcare, Cepheid, Roche Diagnostics, Sysmex Corporation, Zyomyx Incorporation, Hologic Incorporation, Qiagen Incorporation, Siemens Healthcare and Alere Incorporation, Beckman Coulter, Daktari Diagnostics and Janssen Diagnostics.

Browse Related Reports:

Molecular Diagnostics Market Size By Infectious Disease (Flu, Tuberculosis, Meningitis, RSV Virus, Hepatitis B, Hepatitis C, HPV, STD, HIV, Dengue, Gonorrhea, Chlamydia, TORCH, H. Pylori), By Technology (PCR, Real-Time PCR, DNA/RNA Purification), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Portugal, Italy, Russia, Denmark, Norway, Sweden, Israel, Japan, China, India, Sri Lanka, Pakistan, Philippines, South Korea, Australia, New Zealand, Vietnam, Thailand, Mexico, Brazil, Argentina, Colombia, Chile, Peru, South Africa, Nigeria, Morocco, Egypt, KSA, UAE, Jordan, Qatar), Application Potential, Price Trend, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/molecular-diagnostics-market-report

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release HIV Diagnostics Market forecast to grow at 9.5% CAGR up to 2023 here

News-ID: 602234 • Views:

More Releases from Global Market Insights, Inc.

Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key players Eaton, Schneider, Siemens, Hitachi, Powell, Hubbell
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091 Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products. Prenatal vitamin ingredients can

All 5 Releases


More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral